The neurodegenerative disease drugs market was valued at USD 44.69 billion in 2024. Driven by rising Alzheimer’s and Parkinson’s cases across the eight major markets, it is set to grow at a 7.10% CAGR from 2025 to 2034, reaching USD 88.74 billion by 2034. https://www.expertmarketresearch.com/reports/neurodegenerative-diseases-drugs-market